Search results

Selected filters:

Analysis
Chemicals

Article type

Topic

Sector

Regions

Year

97 results found for your search

Sort options
16 January 2020

What IP owners need to know about the US-China trade deal

There are significant gains for branded pharma in the agreement. But in several other areas, China has made commitments it already meets

13 January 2020

Battery tech firm hit with unfair competition claim in China

Chinese company says patent and trade secrets litigation launched by North Carolina-based Celgard in a US court constitutes "slander of the company’s goodwill"

10 January 2020

Everything you need to know about 2019 US district court patent litigation

Apple top defendant again; Eastern District of Texas loses further ground; and other key stats

08 January 2020

Increasing scrutiny for patent filing subsidies in China

Last year patent agencies came under scrutiny for gaming the system, and corporate IP managers say they expect tighter auditing in the year to come

07 January 2020

ITC cases were more China-focused than ever in 2019

But study by Chinese trade body shows that respondents who fight back do surprisingly well

07 January 2020

Federal Circuit delivers good news for process patent owners

A precedential decision last month makes it easier for rights holders to assert successfully against imported products

06 January 2020

Trade secret dispute between LG Chem and SK Innovation shows power of the ITC

The Korean pairs’ fight, which also encompasses US patent litigation, could be a harbinger of similar global conflicts between other big companies

19 December 2019

Oblon McClelland Maier & Neustadt revealed as number one filer for the IAM/ktMINE US Patent Elite

Arlington-based firm acts for more of the companies that own the biggest US portfolios than any other, with Foley & Lardner and Harness Dickey & Pierce rounding out the top three

12 December 2019

Seoul Semiconductor patent auction analysis reveals a mixed bag of assets

In sales due to be held this month and next, the Korean company offers two radically different portfolios. But value is in the eye of the beholder - and a range of businesses could be making bids

09 December 2019

Healthcare and pharma sector sees most patent deals activity in Q3 in the US 

Latest data shows Global Foundries, IV and Seiko among top sellers; NPEs the top buyers, with Samsung, Pinterest and BBK Electronics also among the leaders

09 December 2019

Examination agreement between Japan and India steers clear of life sciences

The two countries inaugurated a Patent Prosecution Highway scheme last week, but it will be one-way traffic when it comes to pharma rights

06 December 2019

Fish & Richardson tops list of firms that the US patent elite use for litigation

More than half the companies that make up the IAM/ktMINE listing of the entities with the biggest US portfolios have instructed Fish lawyers to represent them in district court disputes over the course of the last decade

28 November 2019

Troubled Chinese tech firm seeks to re-assure creditors with patent transfer

One week after missing bond payments, display company says its top shareholder will assign it core patent rights

19 November 2019

Shorter EPO opposition process requires new approaches from life sciences patentees

Strategies employed not only by rights owners but also by those opposing their grants will need to be recalibrated to reflect the new realities

13 November 2019

EPO agreement to boost Chinese companies' Europe push

Foreign companies with R&D in China may also benefit from deal opening up PCT search options